Navigation Links
NYSCF announces 2010 NYSCF Investigators
Date:10/12/2010

PhD, recently joined the faculty of the Institute for Stem Cell Biology and Regenerative Medicine and the Department of Pathology at Stanford University where his lab is working on the epigenetic regulation of stem and somatic cells. The lab recently isolated defined factors that induce the direct conversion of skin fibroblasts into functional neurons. Dr. Wernig, a native of Innsbruck, Austria, studied medicine at the University of Vienna after a successful career as a composer. After clinical studies at the Technical University of Munich, Germany, he joined the lab of Dr. Rudi Balling where he completed his PhD. After a residency program in neuropathology at the University of Bonn under Dr. Otmar D. Wiestler, he joined the lab of Dr. Oliver Brustle, where he worked on neural differentiation of embryonic stem cells. For his postdoctoral training, he worked in the lab of Dr. Rudolf Jaenisch at the Whitehead Institute at MIT, where he spearheaded one of the few research groups worldwide to successfully create pluripotent stem cells from mouse skin cells.

The NYSCF-Helmsley Investigators are:

  • Darja Marolt, PhD, is currently completing her postdoctoral studies at Columbia University in the lab of Dr. Gordana Vunjak-Novakovic. She received her PhD from the University of Ljubljana in Slovenia. Since then, she has been developing tissue engineering approaches to regenerate bone, working at the Blood Transfusion Center of Solvenia and the MIT-Harvard Division of Health Sciences and Technology before coming to Columbia. Dr. Marolt has co- authored almost a dozen research papers for numerous scientific journals.

  • Valentina Fosatti, PhD, received her doctorate at the University of Bologna, and joined the lab of Dr. Hans Snoeck at the Department of Gene and Cell Medicine at the Mount Sinai School of Medicine while she was still a PhD candidate. As a postdoctoral fellow, she focused on the generation of thymic cells from embryonic stem ce
    '/>"/>

Contact: Nadine Woloshin
nwoloshin@rubenstein.com
212-843-8041
New York Stem Cell Foundation
Source:Eurekalert

Page: 1 2 3 4 5

Related biology news :

1. NYSCF Fellow lead author on study that creates blood vessel cells from stem cells
2. NYSCF fellow lead author on study that derives floor plate tissue from embryonic stem cells
3. NYSCF receives $27 million grant from Robertson Foundation to promote stem cell research
4. NYSCF awards fellowships to 8 innovative stem cell scientists
5. NIAID announces 25 new awards to develop radiation countermeasures
6. Aware Announces Q3 2008 Earnings Conference Call
7. Governor Doyle announces historic genomic research collaboration
8. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
9. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
10. Parkinsons Disease Foundation announces award of $150,000
11. Jefferson Department of Surgery announces new pancreas tumor registry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/48tj8z/global_biometrics ... "Global Biometrics Market Forecast and Opportunities, 2020" ... for biometric authentication systems is projected to grow ... The driving forces for this highly ... projects and constant development in technology. In 2014, ...
(Date:3/2/2015)... 2015   Neurotechnology , a provider of high-precision ... SentiGaze Software Development Kit (SDK). The SentiGaze algorithm ... off-the-shelf webcams to track eye movements and generate heatmaps ... Heatmaps can be used for applications such as analysis ... The SDK can also be used to develop interfaces ...
(Date:2/24/2015)... DUBLIN , Feb. 24, 2015 Research ... announced the addition of the "Global 2D ... offering. The analysts forecast the ... a CAGR of 32.12% over the period 2014-2019 ... devices in non-traditional sectors is one of the ...
Breaking Biology News(10 mins):Global Biometrics Market Forecast and Opportunities, 2020 2Global Biometrics Market Forecast and Opportunities, 2020 3Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 2Neurotechnology Releases SentiGaze SDK for Eye Movement Tracking Using Ordinary Webcams 3Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2
... J. Fox Foundation for Parkinson,s Research today announced ... research teams under its Target Validation initiative. This ... to help push potential PD drug targets forward ... million Parkinson,s patients worldwide. "The discovery of ...
... account for almost 50% of crop sales in the ... ensure good quality. But more information is needed about ... changes so that management practices such as irrigation can ... generalize because of variations in crops, planting densities, and ...
... The AIDS Vaccine Advocacy Coalition (AVAC) today urged Dr. Anthony ... Diseases (NIAID) to act swiftly to clarify the path ahead ... with the proposed PAVE 100 AIDS vaccine trial but would, ... also calls on leaders in the field to make clear ...
Cached Biology News:Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinson's 2Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinson's 3Michael J. Fox Foundation awards $2.4M for validation of therapeutic targets for Parkinson's 4Digital cameras, remote satellites measure crop water demand 2AVAC comments on NIAID decision not to move forward with PAVE 100 Trial 2AVAC comments on NIAID decision not to move forward with PAVE 100 Trial 3
(Date:3/4/2015)... , March 4, 2015  BioClinica®, Inc., ... technology provider, today announced that clinical trial ... convened at its annual European User Conference ... to discuss the use of its eClinical ... eClinical technologies include: the Microsoft Office-Smart OnPoint ...
(Date:3/4/2015)... March 4, 2015 Launched ... Paris in December 2011, ,SARAH, - ... resin microspheres versus sorafenib in advanced hepatocellular carcinoma (HCC) ... 2016.   SARAH, a large French study ... carcinoma, or HCC) has completed patient enrolment, exceeding its ...
(Date:3/3/2015)... March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... and molecular diagnostics that target the underlying mechanisms of ... seventh-month period ended December 31, 2014. Effective ... end from May 31 to December 31. As a ... today are for the quarter and the seven months ...
(Date:3/3/2015)... Ky. (PRWEB) March 03, 2015 Experts ... their schedules for one event: the Alltech REBELation exploring ... from May 17-20. Now in its 31st year, Alltech’s ... from 70 countries, and the opportunity to join the ... March 7 at 11:59 p.m. EST, at which point ...
Breaking Biology Technology:BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 2BioClinica Teams With Pharma To Tackle Clinical Trial Challenges In Europe 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 2World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 3World-renowned Leaders, Authors and Businesspeople Join the Alltech REBELation 4
... Mass. and CHICAGO, March 29 Boston,Scientific Corporation ... an analysis,of two-year data from more than 7,000 ... was designed to evaluate the safety performance of ... in "real-world" practice. Outcomes through two years in ...
... MINRAD,International, Inc. (Amex: BUF ) today announced its ... as President and Chief,Operating Officer, effective April 1, 2008, ... Company. Mr. DiGiacinto,s appointment is the,first step in a ... the Company beginning on January 1, 2009. William H. ...
... Aerovance Inc. today,announced it has secured $20 ... the syndicate, which includes Silicon Valley Bank,and Comerica ... financing line,at closing. The remaining $10 million is ... financing reflects continued interest and enthusiasm in Aerovance,and ...
Cached Biology Technology:Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent 2Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent 3Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent 4MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer 2MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer 3MINRAD International, Inc. Announces Appointment of David T. DiGiacinto as President and Chief Operating Officer 4